Stability management in Pharma.

Pharmaceutical company Hemofarm, based in Vršac, Serbia, has started a project with the Matrix Gemini Stability Management System from Autoscribe Informatics. Hemofarm is a member of STADA Group, one of the largest generic pharmaceutical companies in the world. The Matrix Gemini Stability Management System will be for stability studies across Hemofarm’s rich product range of prescription drugs (Rx), over-the-counter medicines (OTC) and consumer healthcare products (CHC products).

John Boother, President of Autoscribe Informatics said, “We are pleased to be working with Hemofarm in their Stability Studies project. As one of the most complete and mature study management systems on the market today, Matrix Gemini Stability continues to gain traction and market share across the pharmaceutical industry. Its highly flexible graphical configuration tools ensure that the system can be configured to each customer’s exact needs, while providing the flexibility for change as the customer’s requirements evolve over time.”

Based on the Matrix Gemini Laboratory Management System, Matrix Gemini Stability helps to simplify the whole stability study management process, which can be complex and time consuming for multiple studies. The in-built stability study management functionality is designed to automate and control the entire operation of the stability study including: protocol creation, study initiation and management, inventory management, sample pull points, future workload reporting and stability study reporting. The system can produce shelf life projections and is also optionally capable of producing projected shelf life trend analysis.

Founded in 1960, Hemofarm is one of the largest domestic producers and exporters of medicines in Serbia. It currently operates in 38 markets over 3 continents and has around 2,500 employees. Hemofarm became a part of STADA group in 2006 and has grown with STADA Group ever since, becoming an important member, especially in the Operations area.

@AutoscribeLtd  #PAuto #Pharma 

Lab Informatics board strengthened.

Jim Aurelio, who has a long and successful track record in the Lab Informatics business, has joined the Autoscribe Informatics’ Board of Directors.

Jim Aurelio

He is based in North America and will work closely with Autoscribe’s Executive team to strengthen strategic and operational plans with a key emphasis on serving the North American Markets.

John Boother, Chairman of Autoscribe Informatics UK, has known Aurelio for close to 35 years as they worked together in the early days of LIMS. Boother said: “I am very pleased to announce Jim’s appointment to Autoscribe’s Board of Directors. As the former President and CEO of LabVantage, Jim is a proven innovative and results driven leader, who brings to Autoscribe vast experience of what it takes to achieve exceptional results with keen emphasis on delivering outstanding customer support. I am really looking forward to working with him again.”

Aurelio brings with him an impressive range of business and management skills coupled with an in-depth knowledge and understanding of the Lab Informatics marketplace. “I am excited to join Autoscribe’s North American team. Matrix Gemini is an extraordinarily versatile software solution. Its rich product functionality, coupled with strong, yet easy to use configuration tools allows us to address the current and future needs of the Lab Informatics market. I am confident that working together as a cohesive team we will deliver strong sales revenue while providing extraordinary customer service to our North American customer base.”

The arrival of Jim Aurelio is the latest in a series of strategic appointments that is strengthening Autoscribe’s senior management team around the world. Autoscribe customers are benefitting from a company structure that includes a number of the most senior, experienced and respected practitioners from the world of LIMS.

@AutoscribeLtd #LIMS #Pauto

Another global informatics partner

Thermo Fisher Scientific has extended its reach across Central Europe by making Vialis AG the latest member of its Informatics Global Partner Alliance. Vialis AG, based in Switzerland, will provide local services and support for the full range of Thermo Scientific informatics solutions, including laboratory information management systems, chromatography data systems, electronic laboratory notebooks and spectroscopy software, as well as comprehensive laboratory automation and integration solutions.

Vialis has built a unique business consultancy based on providing technology and support solutions that deliver on the goal of creating a “paperless lab.” By understanding their customers’ business processes and goals, Vialis offers a complete solution to meet objectives. Through its partnership with Thermo Fisher, they can now provide world-class Thermo Scientific informatics solutions to customers that are assembling a paperless lab. The company will provide full sales, operational and administrative support for the complete portfolio of Thermo Scientific informatics products.

"Our customers will benefit from this new partnership with the global service and sales teams at Thermo Fisher Scientific. By offering best-in-class Thermo Scientific Informatics software, we are able to provide our customers with a comprehensive solution for managing their data and helping ensure that their laboratory workflow meets the demanding business and regulatory requirements in life sciences and other industries,” said Dr. Ulf Fuchslueger, CEO, Vialis AG (pic right).

Dave Champagne, vice president and general manager for Thermo Fisher’s Informatics business, said: “Thermo Fisher’s Global Partner Alliance Program brings together the expertise of sales and services organizations around the world, allowing Thermo Scientific Informatics solutions to be delivered to private and public sector businesses across the broadest range of industries. Vialis offers expertise in life sciences process optimization, specifically in the paperless lab concepts, integrating many normally stand-alone solutions in a single workflow. Our partnership with Vialis will allow us to offer local support and service to an important scientific center in Europe and help us build on our commitment to provide leadership and innovation to the industry.”